Host resistance in liver disease--its evaluation and therapeutic modification.
We have attempted to review some of the factors involved in host resistance and the variations in the individual responses to the infectious and noxious agents to which we are increasingly exposed. Few treatment modalities are available to favorably influence host resistance, but clearly, this approach to the treatment of liver disease represents an opportunity for the future.
D000367:Age Factors; D001402:B-Lymphocytes / Q000276:immunology; D006509:Hepatitis B / Q000188:drug therapy; D006801:Humans; D007109:Immunity; D007372:Interferons / Q000627:therapeutic use; D007694:Killer Cells, Natural / Q000276:immunology; D007978:Levamisole / Q000627:therapeutic use; D008099:Liver / Q000378:metabolism; D008107:Liver Diseases / Q000188:drug therapy / Q000276:immunology* / Q000378:metabolism; D009747:Nutritional Physiological Phenomena; D012737:Sex Factors; D013601:T-Lymphocytes / Q000276:immunology
D007978:Levamisole; D007372:Interferons